BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11195470)

  • 1. Chemopreventive efficacy of promising farnesyltransferase inhibitors.
    Lantry LE; Zhang Z; Crist KA; Wang Y; Hara M; Zeeck A; Lubet RA; You M
    Exp Lung Res; 2000 Dec; 26(8):773-90. PubMed ID: 11195470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Farnesyltransferase inhibitors are potent lung cancer chemopreventive agents in A/J mice with a dominant-negative p53 and/or heterozygous deletion of Ink4a/Arf.
    Zhang Z; Wang Y; Lantry LE; Kastens E; Liu G; Hamilton AD; Sebti SM; Lubet RA; You M
    Oncogene; 2003 Sep; 22(40):6257-65. PubMed ID: 13679864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Farnesyltransferase inhibitors reduce Ras activation and ameliorate acetaminophen-induced liver injury in mice.
    Saha B; Nandi D
    Hepatology; 2009 Nov; 50(5):1547-57. PubMed ID: 19739265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of farnesyltransferase inhibitor FTI-276 on established lung adenomas from A/J mice induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
    Lantry LE; Zhang Z; Yao R; Crist KA; Wang Y; Ohkanda J; Hamilton AD; Sebti SM; Lubet RA; You M
    Carcinogenesis; 2000 Jan; 21(1):113-6. PubMed ID: 10607742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemopreventive effect of perillyl alcohol on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced tumorigenesis in (C3H/HeJ X A/J)F1 mouse lung.
    Lantry LE; Zhang Z; Gao F; Crist KA; Wang Y; Kelloff GJ; Lubet RA; You M
    J Cell Biochem Suppl; 1997; 27():20-5. PubMed ID: 9591189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-Ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenografts.
    Sun J; Qian Y; Hamilton AD; Sebti SM
    Oncogene; 1998 Mar; 16(11):1467-73. PubMed ID: 9525745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of corneal inflammation by the topical use of Ras farnesyltransferase inhibitors: selective inhibition of macrophage localization.
    Sonoda K; Sakamoto T; Yoshikawa H; Ashizuka S; Ohshima Y; Kishihara K; Nomoto K; Ishibashi T; Inomata H
    Invest Ophthalmol Vis Sci; 1998 Nov; 39(12):2245-51. PubMed ID: 9804132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of heat shock protein 70 in adherent ovarian cancer and mesothelioma following treatment with manumycin, a farnesyl transferase inhibitor.
    Hu W; Wu W; Yeung SC; Freedman RS; Kavanagh JJ; Verschraegen CF
    Anticancer Res; 2002; 22(2A):665-72. PubMed ID: 12014635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of COX-2 and induction of apoptosis: two determinants of nonsteroidal anti-inflammatory drugs' chemopreventive efficacies in mouse lung tumorigenesis.
    Yao R; Rioux N; Castonguay A; You M
    Exp Lung Res; 2000 Dec; 26(8):731-42. PubMed ID: 11195467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic identification of heat shock protein 70 as a candidate target for enhancing apoptosis induced by farnesyl transferase inhibitor.
    Hu W; Wu W; Verschraegen CF; Chen L; Mao L; Yeung SC; Kudelka AP; Freedman RS; Kavanagh JJ
    Proteomics; 2003 Oct; 3(10):1904-11. PubMed ID: 14625852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.
    Lobell RB; Omer CA; Abrams MT; Bhimnathwala HG; Brucker MJ; Buser CA; Davide JP; deSolms SJ; Dinsmore CJ; Ellis-Hutchings MS; Kral AM; Liu D; Lumma WC; Machotka SV; Rands E; Williams TM; Graham SL; Hartman GD; Oliff AI; Heimbrook DC; Kohl NE
    Cancer Res; 2001 Dec; 61(24):8758-68. PubMed ID: 11751396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse mammary tumor virus-Ki-rasB transgenic mice develop mammary carcinomas that can be growth-inhibited by a farnesyl:protein transferase inhibitor.
    Omer CA; Chen Z; Diehl RE; Conner MW; Chen HY; Trumbauer ME; Gopal-Truter S; Seeburger G; Bhimnathwala H; Abrams MT; Davide JP; Ellis MS; Gibbs JB; Greenberg I; Koblan KS; Kral AM; Liu D; Lobell RB; Miller PJ; Mosser SD; O'Neill TJ; Rands E; Schaber MD; Senderak ET; Oliff A; Kohl NE
    Cancer Res; 2000 May; 60(10):2680-8. PubMed ID: 10825141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manumycin and gliotoxin derivative KT7595 block Ras farnesylation and cell growth but do not disturb lamin farnesylation and localization in human tumour cells.
    Nagase T; Kawata S; Tamura S; Matsuda Y; Inui Y; Yamasaki E; Ishiguro H; Ito T; Miyagawa J; Mitsui H; Yamamoto K; Kinoshita M; Matsuzawa Y
    Br J Cancer; 1997; 76(8):1001-10. PubMed ID: 9376258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manumycin inhibits farnesyltransferase and induces apoptosis of drug-resistant interleukin 6-producing myeloma cells.
    Frassanito MA; Cusmai A; Piccoli C; Dammacco F
    Br J Haematol; 2002 Jul; 118(1):157-65. PubMed ID: 12100143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive effect of RAS inhibitor manumycin A on aberrant crypt foci formation in the azoxymethane-induced rat colorectal carcinogenesis model.
    Tsuda M; Okamoto K; Muguruma N; Sannomiya K; Nakagawa T; Miyamoto H; Kitamura S; Goji T; Kimura T; Okahisa T; Izumi K; Takayama T
    J Gastroenterol Hepatol; 2013 Oct; 28(10):1616-23. PubMed ID: 23730936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of growth and invasive activity of human pancreatic cancer cells by a farnesyltransferase inhibitor, manumycin.
    Kainuma O; Asano T; Hasegawa M; Kenmochi T; Nakagohri T; Tokoro Y; Isono K
    Pancreas; 1997 Nov; 15(4):379-83. PubMed ID: 9361092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of human pancreatic cancer growth in BALB/c nude mice by manumycin, a farnesyl:protein transferase inhibitor.
    Ito T; Kawata S; Tamura S; Igura T; Nagase T; Miyagawa JI; Yamazaki E; Ishiguro H; Matasuzawa Y
    Jpn J Cancer Res; 1996 Feb; 87(2):113-6. PubMed ID: 8609057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines.
    Lerner EC; Zhang TT; Knowles DB; Qian Y; Hamilton AD; Sebti SM
    Oncogene; 1997 Sep; 15(11):1283-8. PubMed ID: 9315095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ras CAAX peptidomimetic FTI 276 selectively blocks tumor growth in nude mice of a human lung carcinoma with K-Ras mutation and p53 deletion.
    Sun J; Qian Y; Hamilton AD; Sebti SM
    Cancer Res; 1995 Oct; 55(19):4243-7. PubMed ID: 7671229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of chemopreventive effects of 8-methoxypsoralen against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung adenomas.
    Miyazaki M; Yamazaki H; Takeuchi H; Saoo K; Yokohira M; Masumura K; Nohmi T; Funae Y; Imaida K; Kamataki T
    Carcinogenesis; 2005 Nov; 26(11):1947-55. PubMed ID: 15958517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.